Practical considerations in the use of regorafenib in metastatic colorectal cancer

Over the past 20 years, management of patients with metastatic colorectal cancer (mCRC) has improved considerably, leading to increased overall survival and more patients eligible for third- or later-line therapy. Currently, two oral therapies are recommended in the third-line treatment of mCRC, reg...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Med Oncol
Autors principals: Loupakis, Fotios, Antonuzzo, Lorenzo, Bachet, Jean-Baptiste, Kuan, Feng-Che, Macarulla, Teresa, Pietrantonio, Filippo, Xu, Rui-Hua, Taniguchi, Hiroya, Winder, Thomas, Yuki, Satoshi, Zeng, Shan, Bekaii-Saab, Tanios
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7607787/
https://ncbi.nlm.nih.gov/pubmed/33193826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920956862
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars